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Abstract
Spontaneous pain, hyperalgesia as well as sensory abnormalities, autonomic, trophic, and motor disturbances are key
features of Complex Regional Pain Syndrome (CRPS). This study was conceived to comprehensively characterize the
interaction of these symptoms in 118 patients with chronic upper limb CRPS (duration of disease: 43623 months). Disease-
related stress, depression, and the degree of accompanying motor disability were likewise assessed. Stress and depression
were measured by Posttraumatic Stress Symptoms Score and Center for Epidemiological Studies Depression Test. Motor
disability of the affected hand was determined by Sequential Occupational Dexterity Assessment and Michigan Hand
Questionnaire. Sensory changes were assessed by Quantitative Sensory Testing according to the standards of the German
Research Network on Neuropathic Pain. Almost two-thirds of all patients exhibited spontaneous pain at rest. Hand force as
well as hand motor function were found to be substantially impaired. Results of Quantitative Sensory Testing revealed a
distinct pattern of generalized bilateral sensory loss and hyperalgesia, most prominently to blunt pressure. Patients reported
substantial motor complaints confirmed by the objective motor disability testings. Interestingly, patients displayed clinically
relevant levels of stress and depression. We conclude that chronic CRPS is characterized by a combination of ongoing pain,
pain-related disability, stress and depression, potentially triggered by peripheral nerve/tissue damage and ensuing sensory
loss. In order to consolidate the different dimensions of disturbances in chronic CRPS, we developed a model based on
interaction analysis suggesting a complex hierarchical interaction of peripheral (injury/sensory loss) and central factors
(pain/disability/stress/depression) predicting motor dysfunction and hyperalgesia.
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Introduction
Complex Regional Pain Syndrome (CRPS), mostly regarded as
a neuropathic pain disorder, is typically evolving after a minor
trauma of the limb [1]. Besides pain, CRPS displays a multifaceted
clinical pattern consisting of vaso- and sudomotor changes, as well
as trophic and motor disturbances, edema and somatosensory
changes [2]. In consequence, many patients sustain impairments
of hand function persisting even many years after the initial
trauma [3]. The clinical presentation, and therefore the criteria
leading to the diagnosis of CRPS, are mostly applied to patients
with recently emerging, ‘‘acute’’ CRPS [1,4]. Much less is known
about the occurrence of the respective signs and symptoms when
the initial phase of the disease subsides. Furthermore, the
underlying pathophysiology of CRPS is still under debate [5].
Some authors stress the role of peripheral pathomechanisms,
namely peripheral neurogenic inflammation and small fiber
axonal degeneration [6,7]. In addition, autoimmune dysfunction
seems to be involved in CRPS pathomechanisms [8]. Contrari-
wise, a distinguished body of literature supports the involvement of
the central nervous system in terms of sensory as well as motor
adaptive changes [9,10]. More generally, the level of accompany-
ing chronic stress and depression might also account for
somatosensory changes and the level of ongoing or evoked pain
particularly in chronic pain patients [11,12]. However, the degree
of stress and depression in patients with chronic CRPS is not well
characterized. Recently, it has been suggested that the pathophys-
iological mechanisms of CRPS follow a distinct time course, with a
preponderance of peripheral inflammation and beginning of small
fiber degeneration in the acute phase, and progression of small
fiber degeneration as well as central pathomechanisms dominating
the chronic phase of the disease [13]. It is still unclear to which
degree the underlying pathophysiological mechanisms predict the
clinical presentation of CRPS and the resulting outcome of the
disease, although recent studies suggest an interdependency
between the clinical presentation, the underlying pathophysiology
and possible consequences in terms of resulting impairments.
Namely, differences in skin temperature might facilitate the
discrimination between an ongoing peripheral or central patho-
physiology. [14]. So far, many clinical studies focused on the
characterization of different specific aspects of the disease, for
example the degree of neurological changes or the description of
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patients with short duration of the disease with those suffering
from chronic CRPS. Up to now, a comprehensive survey linking
quantitative sensory changes to CRPS symptomatology and the
degree of resulting impairment is still unavailable for patients with
chronic CRPS. In order to expand the knowledge of clinical
characteristics of chronic CRPS and the level of concomitant stress
and depression, as well as to characterize the degree of resulting
hand impairment and disability, this study was performed.
Material and Methods
Patients and Treatment
All patients with a history of CRPS of more than 12 months
diagnosed either by the IASP criteria or the research diagnosis
criteria proposed by Bruehl (Table 1) [2], who had been treated at
the pain clinic of the University of Munich, were contacted by
mail and asked to participate in the study. Until 2001 clinical
diagnosis of CRPS was established by using the IASP criteria.
From 2001, CRPS was diagnosed at our pain clinic by using the
revised diagnosis criteria of Bruehl (Table 1). A total number of
277 patients were identified using computerized data processing,
of which 118 patients gave written informed consent and
participated in the study. The remaining 159 patients could not
be contacted due to an invalid address or refused to participate in
the study. The exact patients’ disposition is illustrated in Figure 1.
The study was approved by the local ethics committee (Ludwig
Maximilian University of Munich, ethics committee), and written
informed consent was obtained by all subjects enrolled in the study
according to the Declaration of Helsinki. All patients were insured
against travel accidents (Insurance Policy Number:
08.715506462). Furthermore, all patients received an allowance
of 20 J for participation in the study.
Patients suffering from CRPS had been treated following the
treatment guidelines of our pain clinic: Treatment invariably
contained physical therapy, occupational therapy and lymph
drainage as long as clinical signs of edema were present. Drug
therapy contained a WHO ladder step I medication (preferably
nonsteroidal antiphlogistics), as well as a drug recommended as a
first line choice for the treatment of neuropathic pain conditions
[17] (Amitriptyline or Gabapentin). In cases of insufficient pain
control (NRS.4), a WHO ladder step II opioid medication
(Tramadol or Tilidine/Naloxone) had been given in addition.
Choice of drug as well as drug dosing had been left to the
discretion of the attending physician. In case of consent, patients
had undergone stellate-ganglion block in order to test for possible
sympathetically maintained pain (SMP).
Quantitative Sensory Testing
All patients received a standardized Quantitative Sensory
Testing (QST) for characterization of a complete somatosensory
phenotype. Testing contained establishment of sensory as well as
thermal detection and pain thresholds, vibration thresholds,
mechanical pain sensitivity, paradoxical heat sensation and
pressure pain thresholds. All tests were performed under minimal
distraction in a silent, air-conditioned room, with an ambient
temperature of 25–26uC. Subjects were seated on a comfortable
chair, and allowed to adapt to the test environment for at least
20 minutes. The course of assessments was explained to the
subjects by written standard patient instructions. QST followed
the protocol suggested by the German Research Network on
Neuropathic Pain (DFNS). All sensory tests were demonstrated in
a remote test area (forearm) not affected by the underlying disease.
The hand affected by the disease was termed ‘‘ipsilateral’’, while
the other hand was termed ‘‘contralateral’’. All tests were
performed at the dorsum of the ipsi- as well as the contralateral
hand, starting at the contralateral side. Thermal testing was
performed using a Medoc Thermal Stimulus Analyser TSA-2001
device (Medoc, Ramat Yishai, Israel) with a computer-controlled
Peltier-based probe. Thermal testing consisted of testing for Cold
Detection Threshold (CDT), Warm Detection Threshold (WDT),
Cold Pain Threshold (CPT) and Heat Pain Threshold (HPT) and
Thermal Sensory Limen (TSL) by using the methods of limits.
Furthermore, a testing for elicitation of Paradoxical Heat
Sensations (PHS) was applied. Mechanical testing consisted of
determination of Mechanical Detection Threshold (MDT),
Vibration Detection Threshold (VDT), Mechanical Pain Thresh-
old (MPT), Mechanical Pain Sensitivity (MPS), Wind-up Ratio
(WUR) and Pressure Pain Threshold (PPT). Furthermore, the
degree of Dynamic Mechanical Allodynia (DMA) was assessed.
Total duration of sensory testing was about 60 minutes. For an
elaborate discussion see Rolke et al. [18,19].
Clinical Assessment
Infrared thermometry (Proscan 510; Dostmann Electronic,
Wertheim-Reicholzheim, Germany) was used for clinical assess-
ment of sympathetic outflow [20]. Skin temperature was measured
three times on glabrous skin aside from skin veins on the back of
Table 1. Proposed modified research diagnostic criteria for CRPS.*
1: Continuing pain which is disproportionate to any inciting event
2: Must report at least one symptom in each of the four following
categories
N Sensory:
reports of hyperesthesia
3: Must display at least one sign in two or more of the following
categories
N Sensory:
evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch)
N Vasomotor:
reports of temperature asymmetry and/or skin color changes and/or skin
color asymmetry
N Vasomotor:
evidence of temperature asymmetry and/or skin color changes and/or
asymmetry
N Sudomotor/edema:
reports of edema and/or sweating changes and/or sweating asymmetry
N Sudomotor/edema:
evidence of edema and/or sweating changes and/or sweating asymmetry
N Motor/trophic:
reports of decreased range of motion and/or motor dysfunction
(weakness, tremor, dystonia) and or throphic changes (hair, nail, skin)
N Motor/trophic:
evidence of decreased range of motion and/or motor dysfunction
(weakness, tremor, dystonia, and/or trophy changes (hair, nail, skin)
*Bruehl S, Harden RN, Galer BS et al. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria.
International Association for the Study of Pain. Pain 1999; 81: 147–154.
doi:10.1371/journal.pone.0018775.t001
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hand. Emissivity was set to 0.96 (i.e. near black body emissivity).
The arithmetic mean was used for further data processing. Mean
temperature differences between the ipsilateral and the contralat-
eral skin temperature were calculated in order to discriminate
patients with ‘‘warm’’ from those with ‘‘cold’’ CRPS. A difference
of $1uC was assumed to be clinically relevant.
Hand edema was assessed using a custom made Lucite
volumeter (13.5*13.5*34.5 cm), with the patient in an upright
position. The testing commenced as described by Stern [21], who
established reference values with the mean volumes of dominant
hands about 9 ml bigger than those of non-dominant hands (test-
retest reliability r=0.91–0.99) [21]. Side-to-side differences
exceeding 5% were considered as pathologic in patients suffering
from CRPS [22].
A standardized clinical examination of CRPS symptomatology
according to the IASP criteria was performed in all patients. The
testing commenced in a given sequence in a silent air-conditioned
room at 23–25uC. Patients were allowed to adopt the environ-
mental terms for at least 15 minutes before testing. All clinical
examinations were performed by one of three experienced
examiners (VH; AB; WK). Assessment started with clinical testing
for mechanical hyperalgesia, mechanic dynamic allodynia as well
as hypoaesthesia. Mechanical hyperalgesia was tested using a blunt
copper wire with a diameter of 1 mm. Mechanic dynamic
allodynia and hypoaesthesia were tested using a mounted Q-tip.
All examinations were carried out on the dorsum of the ipsi- as
well as the contralateral hand, beginning with the contralateral
side. Mechanical hyperalgesia was accounted when painful
sensation elicited on one examined area was considerably more
pronounced than on the contralateral side.
Mechanical allodynia was considered to be present if pain was
evoked by slightly touching the examined areal. Mechanical
hypoaesthesia (loss of touch sensation) was diagnosed when touch
sensation on one side was diminished in side to side comparison.
Sudomotor dysfunction was evaluated in a dichotomous way
(Sweating abnormality: present/absent) in comparison to the
contralateral side. Disturbances of hair as well as nail growth,
changes in skin colour, presence of edema and skin gloss were
judged in an identical manner.
An 11 point Likert scale ranging from 0–10 (Numeric rating
scale NRS) was used to assess the patients’ subjective intensity of
spontaneous ongoing pain. Furthermore, evoked pain accompa-
nying physical strain of the hand was evaluated in an assessed as
either exaggerated by physical strain or not (i.e. present or absent).
Moreover, presence or absence of shoulder or elbow pain was
recorded.
The assessment of hand motion took place in an analogous
setting. Patients underwent goniometric measurements to deter-
mine active range of motion (AROM) of the wrist (extension/
flexion) as well as thumb abduction by using a standard plastic
transparent goniometer. AROM was defined as the maximum
amount of joint motion attained by a subject during active
performance of joint motion. Patients were instructed to move the
respective joint as far as possible. For wrist extension and flexion a
test-retest reliability of .0.90 and inter-observer reliability
coefficients between 0.78 and 0.91 have been reported [23].
Furthermore, the diameter of the hand between D1 and D5
during maximal active finger extension was quantified in cm
(diameter D1–D5), and failure of maximal finger extension in
contrast to the not affected hand was registered (maximal Finger
extension possible/not possible). Moreover, patients were request-
ed to actively flex the distal as well as the proximal interphalangeal
joints (so called ‘‘clenching a small fist’’). Afterwards, patients were
asked to flex the metocarpophalangeal joints as far as possible (so
called ‘‘clenching a big fist’’). An insufficiency to perform one of
the tasks was recorded (possible/impossible). Furthermore, the
maximal deflection deficit between the most affected finger and
the hands’ palm was quantified (Deflection Deficit). Patients were
asked to oppose D1 and D5. Any deficits in opposition were
quantified (Opposition Deficit D1–D5). All measurements were
carried out on both hands respectively. The patients’ ability to
supinate or pronate the wrist as well as the forearm was evaluated
and incapacities were recorded (Supination/Pronation: possible;
partially possible; impossible). Finally, the patients’ ability for
abduction and external rotation of the shoulders was tested. The
patients were asked to place their hands behind their head and
were instructed to reach as far down their spine as possible. Ability
for adduction combined with internal rotation of the shoulders was
evaluated by asking the patients to place their hands behind their
back and to reach as high up their spine as possible. Failure to join
hands was recorded as pathological outcome of the tests.
The muscle strength was measured by means of a hand held
dynamometer (CITEC: Center of Innovative Technic BV; Netherlands)
following a standardized protocol. The utilized dynamometer
measures grip strength in Newton (N) with an accuracy of 0.1%.
All measurements were performed on the ipsi- as well as the
contralateral hand. During the tests, the display was invisible for
the patient. Each test was performed three times each hand, and
the respective arithmetic mean was used for further analysis.
Testing commenced with the patient in a seated position in the
environment described above. Patients were instructed to apply
the maximal possible force. Full-fist grip, three point grip and
pinch-grip were measured [24]. Full fist grip: The patient clinched
his fist around the applicator. Three point grip: Distal phalanx of
Figure 1. Patient disposition. Disposition of patients eligible for the
study. Eligible patients had been treated at the pain clinic and were
diagnosed with chronic CRPS (Duration of disease more than 12
months).
doi:10.1371/journal.pone.0018775.g001
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phalanges of the 2
nd and 3
rd fingers were positioned above it.
Pinch Grip: The distal phalanx of the thumb was placed above the
device, while the radial side of the index fingers’ middle phalanx
was positioned under it.
Hand-related dexterity was evaluated via the ‘‘Sequentional
Occupational Dexterity Assessment’’ (SODA) [25]. The test
measures hand dexterity, defined as a complex of bimanual
functional abilities in activities of daily living and was especially
designed for patients with rheumatoid arthritis. Tasks of the
SODA inter alia contain picking up an envelope, or unscrewing
the cap of a tube of toothpaste. Assessment took place under the
same conditions as described above. Six tasks of the SODA are
unilateral, and six are bilateral. In the unilateral tasks the patient
was requested to use the less affected hand. The investigator rated
the subject performance on each item (0=unable to perform the
task; 1=able to perform the task in a different way, 4=able to
perform the task as requested). Furthermore, after each task the
patient was asked whether the task was difficult to perform
(0=very difficult; 1=some difficulty, 2=not difficult). Summation
of both scores resulted in an evaluation score for each task from 0–
6 (0=unable to perform the task; 6=able to perform the task as
requested without any difficulty). Scores on the individual tasks
were summed, resulting in a total SODA score from 0–108.
Furthermore, patients were asked whether performing the tasks of
the SODA was painful or not, and the SODA-pain score was
determined (range 0–12). For a more detailed discussion of the test
see [25]. To determine hand-specific disability, the Michigan
Hand Outcomes (MHQ), a health and functional status question-
naire designed specifically for assessment of the hand, was used.
The questionnaire contains six distinct scales: (1) overall hand
function, (2) activities of daily living, (3) pain, (4) work
performance, (5) aesthetics, (6) patient’s satisfaction with hand
function. Scoring and interpretation of the data followed an
algorithm described by Chung and colleagues [26].
Psychological Assessment
The German version of the Pain Disability Index (PDI) was
used to measure the pain-related interference with seven distinct
domains of daily life [27].
Symptoms of depression were assessed by means of the German
version of the Center for Epidemiological Studies Depression Test
(CES-D). This test combines twenty questions designed to measure
levels of depression [28,29]. A raw test score of 27 or more is
considered to be the critical limit for the presence of a depressive
episode in pain patients [30].
Intensity and incidence of stress symptoms were measured using
the German Version of the Post-Traumatic Stress Symptom 10-
Questionnaire (PTSS-10) [31]. The PTSS-10 detects the presence
and intensity of stress symptoms as for example sleep disturbances,
nightmares and generalized irritability. The symptoms are rated
by the patients in a scale from 1 (never) to 7 (always). A summary
score .35 is associated with a high probability of fulfilling the
diagnostic criteria for posttraumatic stress disorder (PTSD).
Moreover, all patients completed a validated questionnaire
evaluating different categories of traumatic memory occurring in
the week before the assessment. The number of traumatic
memories recalled was indexed [32].
The German version of the Short Form 36 (SF-36) was
employed to assess the overall health-related quality of life. The
SF-36 is a generic measure independent of age and underlying
disease, assessing the generic health-related quality of life (HRQL)
in eight dimensions (physical functioning, role physical, bodily
pain, general health, vitality, social functioning, role emotional,
mental health) aggregated into two summary scores (physical and
mental health; PCS/MCS). The eight scales and the two summary
scores are scored from 0 to 100, with 0 indicating the worst health
and 100 the best [33].
Data analysis
Nonparametric paired Wilcoxon signed ranks method test was
applied to detect side-to-side differences for scores with nominal or
ordinal data level. Paired t-test was used for side-to-side compar-
isons as well as for group comparisons for data on interval level.
All QST data except CPT/HPT/VDT and PHS were
transformed into decadic logarithms to achieve secondary normal
distributions [18]. To be able to compare sensory data across
different QST parameters data were further transformed into
standard normal distributions (z-normalized) relative to reference
data of the DFNS cohort of healthy subjects [19]. Briefly, all
patient data were normalized to the respective gender and age
group of healthy controls using the equation: z=(individual
value2meanreference data base)/SDreference data base. Significance of
differences from healthy controls was estimated comparing the
patients mean 6 SD obtained by this z-normalization vs. a
standard normal distribution (i.e. mean 6 SD=061) of an equal
number of healthy subjects of the DFNS reference data using the
web-based statistical freeware (Simple Interactive Statistical
Analysis SISA, Uitenbroek 1997; http://home.clara.net/sisa/
binomial.htm) [34]. Recently, QST has been demonstrated to
show a high test-retest and inter-observer reliability, thereby
enabling a comparison of QST results with the age and gender
matched healthy control of the DFNS [35]. Data of SF36 were
normalized as described above to a representative sample of the
US-General population (n=2393).
In order to explore functional interdependence between pain,
sensory, motor and psychological parameters we developed a
network of mutual relations by causal modelling using a modified
method of path analysis following a similar reasoning as current
dynamic causal modelling approaches used in imaging data
[36,37]. Briefly, crosstables of bivariate correlations were calcu-
lated within functional blocks of parameters (e.g. motor param-
eters). Subsequently, multiple correlations using the stepwise
forward method of building regression equations was calculated
to analyse which parameters were the dominant partners
determining correlations between functional blocks of parameters.
When the dominating parameter(s) had been identified (in some
cases more than there one parameter represented a block), median
split analysis was used to assign a direction of prediction
(bidirectional, when median split groups predicted a significant
difference in the correlated parameter, and vice versa; unidirec-
tional, when median split groups predicted significant differences
in the correlated parameter, but not vice versa). For description of
this complex network of interrelations we used the wording
‘‘correlated’’ or ‘‘predicted’’ (implying causal relationship) to
signify correlations that operated either bi- or unidirectional.
Results
A total of 118 patients (91 female and 27 male; i.e. 77.1 and
22.9%) were enrolled in the study (Figure 1). Patients had a mean
age of 58612 years (range: 20–84 years. Mean duration of disease
since inciting event was 42623 months (range: 12–163 months;
median 37.5 months). 105 patients were right-handed (89%), six
patients were left-handed (5.1%), and seven patients were
functionally bimanual (5.9%). The disease affected the right hand
in 62 (52.5%) and the left hand in 56 patients (47.5%).
Sensory & Motor Signs in CRPS
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The average limb volume of the contralateral hand was
480.4681.5 ml, while the volume of the affected hand was
significantly reduced (469.2683.4 ml; p,0.05; p,0.001 after
correction for hand dominance. Volume reduction at the affected
hand was pathological (reduction .5%, i.e. 24 ml) in 36/118
patients (31.3%), while only 16/118 (13.9%) exhibited patholog-
ical volume enlargement suggestive of hand edema. The
quantitative assessments were corroborated by standardised
clinical examination identifying 30/118 patients (25.4%) display-
ing clinically relevant signs of edema (assessment of volume
reduction was not feasible by clinical examination).
Patients with chronic CRPS displayed a statistically significantly
lower hand temperature at the affected hand albeit differences
were small (hand dorsal affected: 32.761.7uC; contralateral:
33.061.5uC; p,0.01; hand palm: affected: 33.761.5uC; contra-
lateral: 33.961.2uC; p,0.05). A total of 48 patients (40.7%)
displayed abnormal skin colour at the affected hand, with 15
patients exhibiting glossy skin (12.7%). Twelve of these 15 patients
displayed combined skin discolouration and glossy skin.
Clinical assessment of sudomotor or trophic changes revealed
the presence of enhanced sweating at the affected hand in 24
patients (20.3%), and in two patients (1.7%) at the contralateral
hand. One of the two patients was affected bilaterally. Nine
patients (7.6%) complained of augmented hair growth at the site of
chronic CRPS, while disturbed nail growth was found in 23/118
patients (19.5%). Two patients had disturbed contralateral nail
growth (1.7%), in one patient affecting solely the contralateral
extremity (Figure 2).
The majority of patients (77/118=65.3%) reported spontane-
ous ongoing pain (44 patients with pain scores $4=37.3%). Only
41/118 patients were completely pain-free at rest (mean NRS-
score: 2.862.7; median NRS-score: 3) (Figure 3). A few patients
(4/118=3.4%) reported pain at rest at the contralateral hand
(NRS scores $5 respectively). A substantial proportion of patients
complained of exaggerated pain during physical strain of the hand
(95/118=80.5% at the affected, and 13/118=11.0% at the
contralateral hand). Furthermore, nearly half of the patients
complained of secondary pain radiating to the ipsilateral elbow
(57/118=48.3%), or shoulder (47/118=39.8%). On the con-
trary, the percentage of patients with pain at the contralateral
elbow or shoulder was marginal. Interestingly, by means of clinical
neurological examination using side to side differences, merely
11% of the patients were identified to show signs of hypoaesthesia,
and 29.7% were classified as patients with clinical hyperalgesia
(Table 2).
Quantitative Sensory Testing (QST)
Detection Thresholds. Patients exhibited a highly signi-
ficant loss of thermal (z-values for CDT: 21.3761.57; WDT:
21.4261.66; and TSL: 21.4361.37) and mechanical detection
(MDT: 21.5361.29; VDT: 21.1561.97) at the affected hand
compared to age and gender-matched healthy controls (all
p,,0.0001). Notably, the same highly significant thermal as
well as mechanical hypoesthesia also occurred at the contralateral
hand, albeit to a lesser extent (CDT: 20.9261.31; WDT:
21.0761.36; TSL: 21.0261.32; MDT: 20.8161.07; VDT:
21.2362.30; all p,,0.0001). Thus, sensory loss was
homogeneously encountered in any non-painful somatosensory
modality. Average somatosensory loss was 21.38 standard
deviations (z-values) at the affected hand, and 21.01 SD at the
contralateral hand (Figure 4).
Figure 2. Clinical assessment of sudomotor dysfunction, throphic dysfunction, and edema. Bars represent the percentage of patients
displaying the respective signs or symptoms. Significance: * p,0.05 ipsilateral hand vs. contralateral hand, Wilcoxon signed ranks method test.
doi:10.1371/journal.pone.0018775.g002
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significantly decreased, indicating cold and heat hyperalgesia
(HPT: 0.6061.50; CPT: 1.0161.23; both p,0.001). Additionally,
a striking hyperalgesia to painful blunt pressure was found (PPT:
2.8162.75; p,,0.0001). Likewise, the pain threshold to pin prick
was lowered, and pain ratings to suprathreshold pin pricks were
increased (MPT: 0.5161.24; MPS: 0.6661.66; both p,0.001).
Moreover, a statistically significant, albeit small degree of dynamic
mechanical allodynia occurred (DMA: 0.19; log10 pain rating
20.71060.639; p,0.01). However, pain summation at the
affected hand remained unaltered (WUR: 0.1460.93; p=0.27).
Significant hyperalgesia was also encountered contralaterally
throughout all pain parameters (CPT: 0.7561.22, p,0.0001;
HPT: 0.3261.40, p=0.052 PPT: 0.9661.84, p,0.0001; MPT:
0.3360.87, p,0.01; MPS: 0.4161.53, p,0.05; DMA: 0.15; log10
pain rating 20.82260.475; p,0.01). Although marginally more
frequent, the incidence of paradoxical heat sensations (PHS) was
indifferent from healthy controls (0.1460.50 ipsilateral, 0.1160.57
contralateral; p=0.18 and 0.30, respectively). Thus, sensory gain,
i.e. hyperalgesia was encountered in any painful somatosensory
modality. Average pain sensitivity was above normal thresholds by
+1.12 standard deviations at the affected hand, and +0.55
standard deviations at the contralateral hand. QST results are
summarized in Figure 4.
Assessment of Hand Motor Function
Hand force at the affected hand as measured by dynamometry
was significantly reduced in any test. Force reduction (235–40%)
was homogeneous throughout all tests performed, namely
98.4674.8 N vs. 163.4683.38 N for fist grip, 46.2630.0 N vs.
74.4648.4 N for three point grip, and 25.4617.6 vs. 39.1619.9 N
for pinch grip; affected vs. contralateral hand respectively; all
p,0.001 (Figure 5).
Patients with chronic CPRS displayed significant motor
impairments as revealed by several measures, including the ability
to clench a fist, to maximally extend the fingers, or to supinate the
wrist and forearm (all p,0.001 compared to the contralateral
side). However, impaired pronation of the wrist or forearm, as well
as a disability to rotate the ipsilateral shoulder was rarely seen
(Figure 6). Furthermore, active range of wrist motion (flexion and
extension), thumb abduction as well as maximally achievable hand
extension were all considerably reduced (all p,0.001 compared to
the contralateral side). The majority of patients (71/118=60.2%)
were unable to completely clench a fist at the affected hand (only
7/118=5.9% at the contralateral side). Mean deflection deficit (all
patients) at the affected hand was 23.7624.5 mm, and
40.1619.7 mm in patients with deflection deficits. Moreover, 19
patients displayed a D1–D5 opposition deficit at the affected hand
(all patients 6.5619.3 mm; 39.2631.6 mm in the 19 patients with
opposition deficit). Contralateral D1–D5 finger opposition deficit
was only seen in 2 patients (40 mm and 50 mm, respectively).
Table 3 summarises these motor results.
Figure 3. Pain at rest by means of Numeric Rating Scale (NRS). 0 indicates no pain at rest, and 10 indicating the worst pain. Bars display the
percentage of patients in the respective category. The majority of patients (77/118=65.3%) reported spontaneous ongoing pain (44 patients with
pain scores $4=37.3%). Mean NRS-score: 2.862.7; median NRS-score: 3.
doi:10.1371/journal.pone.0018775.g003
Table 2. Pain assessment and clinical somatosensory testing.
Ipsilateral Hand
Contralateral
Hand
Pain During Physical
Strain
80.5% (n=95) 11% (n=13)
Elbow Pain 48.3% (n=57) 6% (n=7)
Shoulder Pain 39.8% (n=47) 5.1% (n=6)
Mechanical Hyperalgesia 29.7% (n=35) 1.7% (n=2) P,0.001
Hypoaesthesia 11% (n=13) 0.8% (n=1) P,0.001
Mechanic Dynamic
Allodynia
5.1% (n=6) 0% P,0.05
doi:10.1371/journal.pone.0018775.t002
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SODA pain-score was 2.163.2 (SODA pain-score ranges from 0
to 12). The overall score of the Michigan Hand Outcome
Questionnaire (MHQ) was 53.0615.0 (range: 22–84). Further-
more, all subscores of the MHQ displayed significant hand
disability (Table 4).
Figure 4. Standardized comparison of QST data normalized to mean and standard deviation of the control group (z-normalisation).
A: Somatosensory profile of thermal and mechanical thresholds: Thermal Detection Thresholds: CDT: Cold Detection Threshold; WDT: Warm
Detection Threshold; TSL: Thermal Sensory Limen. Thermal Pain Thresholds: CPT: Cold Pain Threshold; HPT: Heat Pain Threshold. Mechanical Pain
Thresholds: PPT: Pressure Pain Threshold; MPT: Mechanical Pain Threshold; MPS: Mechanical Pain Sensitivity; WUR: Wind-up ratio. Mechanical
Detection Thresholds: MDT: Mechanical Detection Threshold; VDT: Vibration Detection Threshold. B: PHS: Paradoxical Heat Sensation (PHS); Dynamic
Mechanical Allodynia (DMA). Significance: ipsilateral hand vs. control: * p,0.05. Significance contralateral hand vs. control: + p,0.05. Patients with
chronic CRPS displayed a bilateral hyperalgesia in every painful somatosensory modality as well as bilateral somatosensory loss.
doi:10.1371/journal.pone.0018775.g004
Figure 5. Hand force in chronic CRPS. Bars show a homogeneous reduction of hand force in Newton as compared to the contralateral side
throughout the applied tasks. Significance: * p,0.001 ipsilateral vs. contralateral hand, paired t-test.
doi:10.1371/journal.pone.0018775.g005
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Pain disability index averaged 24.2620.3. Average CES-D
scores were 37.0611.3, thereby considerably exceeding the limit
(CES-D: .27) to diagnose a depressive episode in pain patients.
Notably, 97/118 patients (82%) had a CES-D score of above 27.
Mean PTSS-10 sum score amounted to 28.7612.7 (median score:
27). 32/118 patients (27.4%) displayed a PTSS-10 higher than the
cut-off of 35 reported in the literature. The majority of patients
with chronic CRPS (89/118=75.4%) reported multiple traumatic
memories (Table 5). Mean number of traumatic memories was
1.4861.24. Patients with chronic CRPS displayed significantly
decreased health related quality of life in seven of the eight
dimensions of the SF36 (p,0.0015), with the only exception of the
dimension vitality (Table 6).
Differences between Patients with ‘‘Warm’’ and ‘‘Cold’’
CRPS and Patients Showing Significant Hand
Discoloration
Merely three patients displayed a temperature difference of
more than +1uCelsius and were therefore classified as warm
CRPS, while sixteen patients had a temperature difference
between the ipsi- and the contralateral hand of $21uC and were
therefore classified as ‘‘cold’’ CRPS. Patients with ‘‘warm’’ CRPS
displayed more spontaneous pain, (NRS: 5.762.1; PDI 51612.8)
than patients with ‘‘cold’’ CPRS (NRS: 3.362.8; PDI: 30.6622);
but differences were not statistically significance probably due to
the small number of patients in each group. Furthermore, no
differences in hand volumes or significant differences in QST
between patients with ‘‘warm’’ or cold CRPS could be detected.
Contrariwise, patients displaying hand discoloration at the time of
assessment, had significantly more spontaneous pain (NRS: 462.5;
PDI 32619.1) compared to patients without signs of hand
discoloration (NRS: 1.962.4; PDI 18.8619.6) (p,0.001). Fur-
thermore, patients with hand discoloration displayed significantly
Figure 6. Impairment of hand motor function. Bars display the percentage of patients displaying the respective motor impairment. Significance:
*p ,0.001 ipsilateral vs. contralateral hand, Wilcoxon signed ranks method test.
doi:10.1371/journal.pone.0018775.g006
Table 3. Active range of motion.
Ipsilateral Hand
Contralateral
Hand p-Value
Wrist Extension 52.2u614.5u 63.5611.5u ,0.001
a
Wrist Flexion 56.3u616.5u 70.2610.5u ,0.001
a
Thumb Abduction 50.869.7u 55.68.7u ,0.001
a
Diameter D1–D5 16.863.7 cm 19.262c m ,0.001
a
Deflection Deficit 2.462.4 cm 0.361.2 cm ,0.001
a
Opposition Deficit D1–
D5
0.661.9 cm 0.160.56 cm ,0.01
a
aPaired t-test.
doi:10.1371/journal.pone.0018775.t003
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patients without hand discoloration; PPT: 3.9663.33 in patients
displaying hand discoloration; p,0.001). Moreover, no other ipsi-
or contralateral changes in QST parameters or significant
differences in hand volume could be detected.
Interdependence of Pain, Stress, Depression, Sensory
Changes and Hand Motor Function
Correlation analysis encompassing all estimated parameters
revealed several functional complexes. Ongoing pain and pain-
related disability (PDI) (r=0.75, p,0.0001), as well as posttrau-
matic stress (PTSS-10) and depression (CES-D) were highly
correlated (r=0.76, p,0.0001). There were also highly significant
correlations between these two blocks of parameters (r=0.41–
0.64, all p,0.0001). Median split analysis suggested that none of
these relationships was unidirectional (Figure 7). Additionally, pain
and PDI were significantly predicted by sensory loss (combined
thermal and mechanoreceptive deficit), which remained highly
significant in multiple correlation analysis even after removing the
stronger impact of stress and depression (partial r=0.37 and 0.45,
both p,0.0001). Median split analysis revealed that pain and
pain-related disability were significantly predicted by the magni-
tude of sensory loss, but not vice versa.
Scores of both methods of comprehensive objective and
subjective motor function assessment (SODA and MHQ) were
strongly predicted by ongoing pain (r=20.59 and r=20.60, both
p,0.0001) and pain-related disability (r=20.70 and r=20.79,
both p,0.0001). Median split analysis revealed that VAS or PDI
were highly significantly predictive for differences in SODA or
MHQ (all p,0.0001), but not vice versa (all p.0.20) suggesting
that motor disturbances were predicted by pain and PDI rather
than correlated.
Hyperalgesia was analysed using the QST parameter exhibiting
the most prominent gain, namely blunt pressure pain (PPT).
Combined correlation and median split analysis revealed that
hyperalgesia to blunt pressure stimuli was highly significantly
predicted by motor dysfunction (SODA and MHQ, both
p,0.0001), and to a lesser albeit significant degree by pain or
PDI (both p,0.0001). In contrast, hyperalgesia was only weakly
predicted by posttraumatic stress (r=20.23; p,0.05) and not at
all by depression (r=20.13, p=0.17). An overview on correla-
tional and predictive interaction of sensory function, pain,
hyperalgesia, and motor and psychological functioning is depicted
in Figure 7.
Discussion
Chronic CRPS was characterized by chronic pain at rest and
during exercise, combined with substantially limited hand force
and impaired motor function. Accordingly, the resulting overall
hand function was substantially disabled even several years after
the initial trauma. Chronic CRPS patients exhibited pronounced
bilateral sensory changes revealed by QST, namely hyperalgesia
and sensory loss. Furthermore, patients exhibited a clinically
relevant degree of chronic stress as well as signs of depression. In
contrast, patients with chronic CRPS displayed only marginal
vasomotor, trophic or sudomotor changes.
Pain and somatosensory changes in chronic CRPS
The majority of patients with chronic CRPS complained about
spontaneous pain. The observed proportion is comparable to
outcome studies in patients with childhood-onset of CRPS and a
Table 4. Michigan Health Questionnaire: (MHQ).
Score
Overall Hand Function (MHQ I) 48.75u6u24.1
Activities of Daily Lifer (MHQ II) 44.75u6u30.3
Work Performance (MHQ III) 50.5u6u25.3
Pain (MHQ IV) 47.6u6u28.9
Aesthetics (MHQ V) 65.5u6u25.57
Satisfaction with Hand Function (MHQ VI) 56.9u6u23
Overall MHQ Score 53u±u15
Hand disability measured with MHQ: For the pain scale, higher scores indicate
more pain. For the other scales, higher scores indicate better hand
performance. Scores are normalized to a range from 0–100.
doi:10.1371/journal.pone.0018775.t004
Table 5. Number of traumatic memories.
% (n) PTSS-10 Score
No Traumatic Memories 24.6 17 17.3u6u7.2
One Traumatic Memory 33.3 23 21.9u6u6
Two Traumatic Memories 20.3 14 36.5u6u10.8
Three Traumatic Memories 13 9 37.9u6u11.2
Four Traumatic Memories 8.7 6 45.4u6u12.7
Mean Number of Traumatic
Memories
1.48u6u1.244 28.7u6u12.7
doi:10.1371/journal.pone.0018775.t005
Table 6. Health related quality of life: (SF-36).
Mean±SD Z-Score p
PF 58.2u6u26.6 21.1u6u1.2 ,0.05
RP 45.8u6u39.3 21u6u1.2 ,0.05
BP 57.3u6u23 20.8u6u1 ,0.05
GH 47.7u6u11.4 21.2u6u0.6 ,0.05
VT 58.4u6u12.8 20.1u6u0.6 n.s.
SF 70.6u6u13.4 20.6u6u0.6 ,0.05
RE 52.4u6u40.8 20.9u6u1.2 ,0.05
MH 49u6u14.8 21.4u6u0.8 ,0.05
PCS 41.5u6u10 -
MCS 41.9u6u4.6 -
The scales of the SF-36 score from 0–100, with 0 indicating worst health and
100 the best.
PF: Physical Functioning.
RP: Role Limitations, Physical:
BP: Bodily Pain.
GH: General Health.
VT: Vitality.
SF: Social Functioning.
RE: Role Limitations, Emotional.
MH: Emotional Well-Being.
PCS: Physical Component Summary Score MCS: Mental Component Summary
Score.
t0: Before beginning of treatment.
t1: One year after beginning of treatment.
n.s.: Not significant.
Z-Score: SF-36 data were normalized to a US-General population (n=2393).
doi:10.1371/journal.pone.0018775.t006
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populationbasedstudybydeMosetal.examiningchronicCRPSin
adults reported spontaneous pain in about 30% of all cases [39].
The large number of patients complaining of pain during physical
strain as well as relevant pain-related interference with activities of
daily life, indicated by the elevated PDI, further illustrates the
impactof painon patients even several years after the initialtrauma.
The somatosensory QST profiles display a combination of a
bilateral mechanical and thermal hyperalgesia, with the hallmark
sign of blunt pressure hyperalgesia, as well as bilateral thermal and
mechanical hypoaesthesia of a similar magnitude in all thermal and
mechanical non-nociceptive modalities. Sensitivity was uniformly
lowered by approximately 1.4 standard deviations ipsilaterally and
1.0 standard deviations contralaterally, comparable to previous
findings [13,14,40]. Elevated detection thresholds for mechanical
and thermal stimuli can be attributed to a loss of small Ad and C-
fibers, thereby supporting the potential role of small fiber loss in the
pathophysiology of the disease [5]. However, in the absence of
structural changes, tactile hypoaesthesia might be generated by
functional impairments of sensory pathways, namely a central
inhibition of non-noxious pathways [14]. Heterosynaptic long term
potentiation (LTP) of inhibitory spinal interneurons has been
discussed as a possible pathomechanism in this context [41]. The
combination of a distinct cold hyperalgesia, absence of PHS and a
minor heat pain hyperalgesia, likewise indicates a preponderance of
small fibre degeneration, while QST signs of inflammatory
hyperalgesia were almost absent [13,42]. The relative contribution
of Ad- and C-nociceptors to pressure pain threshold is only partially
resolved and peripheral as well as central mechanisms of action are
supposed to be involved [19,43,44]. The bilateral somatosensory
changes, which have been described for thermal thresholds before,
likewise suggest the involvement of spinal or supraspinal structures
[13]. Therefore, in chronic CRPS signs of small fibre degeneration
combined with indicators of a central sensitization dominate the
QST results. Importantly, the clinical somatosensory examination
was not sufficiently capable to reveal these pronounced somatosen-
sory changes, stressing the importance and higher sensitivity of a
standardized QST examination.
Motor Dysfunction in Chronic CRPS
Because motor dysfunction was not a ‘‘conditio sine qua non’’ in
former diagnostic criteria of CRPS, many studies do not report the
amount of motor changes in CRPS or confine to describe
manifestations of existing motor deficits [1,45,46]. Hand force was
substantially lowered by about 40% throughout all tests conduct-
ed, thereby exceeding the previously reported amount of force
impairment in patients with chronic CRPS [24]. The differences
in active range of motion found are conspicuous, when the affected
and unaffected hands are compared. However, the results were
still within a range required to perform activities of daily life [24].
The deficits in finger movements, as quantified by the impaired fist
clenching ability and deflection/opposition deficits have not been
quantified before. The pathophysiology of ongoing motor
dysfunction in this late stage of the disease might be attributed
to conglutinations of peripheral joints and tissues as signalled by
the deficits in finger and wrist movements, thereby representing
long-term consequences of an initial inflammatory process.
However, these impairments can likewise be attributed to adaptive
changes in central motor processing characterized by lower levels
of motor cortical activation [9,47]. Moreover, ongoing chronic
pain accounting for increasing fear of movement, might similarly
contribute to the measured level of hand function impairment.
Kinesophobia as well as the level of ongoing pain have both been
associated with a decreased level of muscle activation in a model of
chronic musculoskeletal neck pain [48]. A proper distinction
between peripheral or central motor changes or the degree of
kinesophobia was impossible, as all movement tasks were only
actively performed by the patients.
Vasomotor-, sudomotor-, trophic dysfunction and edema
in chronic CRPS
In contrast to the distinct somatosensory and motor alterations,
other symptoms of CRPS were by far less present. Of these
changes, skin discolouration was most frequently noted with an
incidence of about 40%. In contrast to patients with acute CRPS,
in which hand edema and clinical aspects of a ‘‘warm’’ hand
dominates, the volume of the affected hand was significantly
Figure 7. Overview on correlational and predictive interaction of sensory function, pain, hyperalgesia, and motor and
psychological functioning. Multiple correlation was calculated to analyse correlations between functional blocks of parameters using the
stepwise forward method of building regression equations. Median split analysis was then applied to assign direction of influence of parameters
included in the regression equation, i.e. to identify predictors.
doi:10.1371/journal.pone.0018775.g007
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the hand affected by CRPS appeared ‘‘colder’’ [49]. Both, edema
as well as increased skin temperature, signal ongoing peripheral
inflammation [50]. Moreover, the clinical signs of autonomic
dysfunction like hyperhidrosis and alterations of hair growth were
only moderately present, when compared to acute CRPS [45]. As
the presence of an inducible autonomic nervous system autoan-
tigen has been recently demonstrated in CRPS patients, one may
speculate about possible interactions between autoimmune and
inflammatory processes dominating the acute phase of CRPS,
whereas in chronic CRPS the clinical signs of peripheral
neurogenic inflammation and autonomic dysfunction may have
mostly subsided due to post-inflammatory burn-out.
Recently, it has been suggested that patients with ‘‘warm’’ and
‘‘cold’’ CRPS (i.e. a significantly warmer or colder hand affected
by CRPS when compared to the contralateral side), might be
representatives of a more peripheral or central pathophysiology of
the disease [14]. Furthermore, it has been demonstrated that
patients initially classified as ‘‘cold’’ CRPS showed more pain
when re-evaluated several years after the initial assessment [3].
‘‘Warm’’ CRPS seems to be predominant in the acute phase of
CRPS, where signs of peripheral neurogenic inflammation
dominate [13]. Therefore, as patients in our study suffered from
chronic CRPS with duration of disease of at least one year, only
few patients with ‘‘warm’’ CRPS could be identified, and no
differences between ‘‘warm’’ and ‘‘cold’’ CRPS could be detected.
In addition, we were unaware of the patient’s initial classification
into either ‘‘warm’’ or ‘‘cold’’ at the time the CRPS was
diagnosed.
While only few patients displayed signs of significant temper-
ature differences between both hands, a considerable proportion of
patients with chronic CRPS showed hand discoloration, which
can, like temperature differences, also be interpreted as a sign of an
ongoing vasomotor instability [51]. These patients had signifi-
cantly more spontaneous pain, when compared to those without
apparent skin discoloration. While the pathophysiological meaning
of skin discoloration remains unclear, it might nevertheless serve as
an easy to detect clinical sign in order to evaluate the severity of
the ongoing disease.
Stress and Depression in Chronic CRPS
While psychological factors do not seem to be associated with
the onset of CRPS [52], patients in this study showed clinically
relevant levels of both chronic stress and depression. Their median
PTSS-10 score was comparable to patients surviving life
threatening events resulting in long-term critical care therapy like
sepsis or acute respiratory distress syndrome (ARDS) [53].
Recently, a diffusion tensor imaging study of patients with CRPS
displayed grey and white matter abnormalities in the ventromedial
prefrontal cortex, a brain area associated with the development
and maintenance of posttraumatic stress disorder (PTSD) [54,55].
Furthermore, CRPS patients exhibit signs of an impaired innate
immunity, presumably reflecting the immunological consequences
of an immunosuppressive neuroendocrine stress response [32].
Interestingly, CRPS has been reported to be elicited by stress
exacerbation in patients with PTSD [56]. Furthermore, PTSD
patients show high rates of concomitant chronic pain, and the
severity of chronic pain in PTSD seems to be closely correlated to
the degree of stress [56]. Likewise, substantial correlations were
shown in this study between the levels of stress and depression, and
the degree of ongoing pain and pain-related disability. Finally,
concerning somatosensory thresholds, in analogy to the correlation
between evoked pain (PPT) and stress levels in this study, an
influence of PTSD and depressive symptoms on QST results has
been described [11,12]. Summarized, similar to critical care
patients suffering from sepsis, onset of PTSD in patients with
CPRS might be triggered by an inciting inflammatory event, but
in contrast to critical care patients in CRPS, chronic stress may
perpetuate the progression of the disease [57]. This hypothesis is
further supported by combined correlation and median split
analysis, showing a significant prediction of hyperalgesia and
motor dysfunction by the closely interrelated cluster of ongoing
pain, pain-related disability, stress and depression (Figure 7).
Hand Disability, Dexterity and Central Maladaptation in
Chronic CRPS
Chronic CRPS patients displayed a considerable degree of hand
disability and impaired hand dexterity, comparable to patients
with rheumatoid arthritis and mobile swan neck deformities [58].
Hence patients with chronic CRPS sustain a pronounced
interference with the accomplishments of daily life, even years
after the initial trauma, further emphasized by the reduced general
health related quality of life. This is emphasized by the high rate
patients found to be incapable to work even several years after the
initial treatment in a study by de Mos et al [39]. The dissection of
factors possibly influencing the degree of hand disability revealed
that the degree of ongoing pain and pain-related disability was the
most important factor in prediction of manual motor disturbance
(see Figure 7). This suggests a participation of higher central
mechanisms of (mal-)adaptation.
Chronic pain disrupts the so-called ‘‘default mode network’’ of
the brain [59] and may lead to widespread structural changes of
the in animal as well as human brain [60,61] Reduced neuronal
metabolism in several brain regions has been demonstrated by
magnetic resonance spectroscopy [62]. These maladaptive plas-
ticity mechanisms of the CNS are also known from pathologies like
phantom limb-related disorders [63] Similar maladaptive plasticity
also occurs in CRPS [64–66], but may be reversible by successful
rehabilitation and concomitant pain reduction [65,67] Several
structural changes suggestive of functional loss have been
demonstrated in the brain of CRPS patients, e.g. regional atrophy
in brain areas involved in pain processing, like insula and
prefrontal cortex, as well as decreased connectivity between
prefrontal cortex and the basal ganglia [54]. The basal ganglia,
especially the putamen, are not only involved in descending pain
control but moreover in the pathophysiology of other motor
disorders, like Parkinson’s disease or restless legs syndrome [68–
70]. These syndromes are also presenting with spontaneous pain
and/or hyperalgesia by hitherto unexplained mechanisms [71,72].
Recently, a net shift from inhibitory towards facilitatory pain
control has been demonstrated in CRPS patients [73]. In
aggregate, there is ample evidence on putative central mechanisms
suggesting that the motor disorders in CRPS may be elicited by
the level of concomitant pain. However, due to the study design,
the results could not be compared to a similar group of patients
suffering from other chronic pain syndromes like fibromyalgia or
chronic low back pain. Therefore it remains unclear if these
interactions between chronic pain, stress, depression and motor
disorder are specific features of CRPS, or just reflect a general
characteristic of any kind of chronic pain [74].
Study Limitations
As the study design is not prospective, a potential recruitment
bias must be taken into account. Overall, 86 patients which had
been contacted, refused to participate in the study. Moreover, 67
eligible patients could not be contacted, and six patients deceased
(Figure 1). However, only few of the patients refusing to participate
in the study reported to be pain-free, while others reported that
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indicated to be discontent with prior treatment at the pain clinic.
QST is a behavioural functional measure of somatosensory
function, and none of the performed tests provides a direct
evidence of structural changes in either the peripheral or the
central nervous system [75,76]. Furthermore, the applied therapies
were not prospectively controlled, but followed the standard
therapy guidelines of our pain department at the time of the
patients’ initial attendance. Therefore, possible interactions
resulting from different therapeutic regimens can not be ruled
out, but are unlikely due to the high number of patients included
in the study.
Taken together, one can speculate about the following
mechanisms interacting in the pathophysiology of CRPS: Initial
sensory loss, possibly caused by a peripheral neurogenic
inflammation, accounts for the inducting of ongoing pain. The
degree of ongoing ‘‘central’’ pain, depression and stress,
determines the development and degree of hand dysfunction
and the amount of evoked pain in chronic CRPS (Figure 8). In
summary, chronic CRPS in characterized by a combination of
chronic ongoing as well as evoked pain, a distinct level of stress
and depression, resulting in a disabled hand function even years
after the impressive symptoms of acute CRPS like edema and
sympathetic dysfunction subside. Hence, in the future enhanced
efforts should be made to set up tailored treatment strategies
targeting underlying pathomechanisms in order to improve long
term outcome even in severe cases of CRPS.
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